In aggregate, these findings uncover an unrecognized pathway that p-α-synuclein deposits in vagal SCs and induces a neuroinflammatory response involved in the development of AutD, providing a novel strategy and molecular target for the diagnosis and treatment of AutD in prodromal PD. Here, SNCA is linked to Parkinson disease.